SCHEMBL737708

SCHEMBL737708

C[C]1CCc2ccccc2O1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAOA P21397 2/20 0.50
MAOB P27338 2/20 0.50
GAA P10253 1/20 0.39
NPSR1 Q6W5P4 1/20 0.39
ORAI1 Q96D31 1/20 0.37
ORAI2 Q96SN7 1/20 0.37
ORAI3 Q9BRQ5 1/20 0.37
SETD7 Q8WTS6 1/20 0.35
NPC1 O15118 1/20 0.35
LMNA P02545 1/20 0.35
RAB9A P51151 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
TSHR P16473 1/20 0.35
ABCG2 Q9UNQ0 1/20 0.33
CES1 P23141 1/20 0.33
ITGB2 P05107 1/20 0.33
ICAM1 P05362 1/20 0.33
ITGAL P20701 1/20 0.33
OXTR P30559 1/20 0.33
CYP2A6 P11509 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30360775 0.83 MAOA (0.70) MAOAMAOBGAANPSR1ORAI1
SCHEMBL971330 0.83 MAOA (0.70) MAOAMAOBGAANPSR1ORAI1
SCHEMBL8470353 0.79 MAOA (0.65) MAOAMAOBGAANPSR1NPC1
SCHEMBL19821087 0.75 MAOA (0.48) MAOAMAOBGAANPSR1SETD7
SCHEMBL4500547 0.73 MAOA (0.64) MAOAMAOBGAANPSR1SETD7
Dihydrocoumarin SCHEMBL17629427 0.73 MAOB (0.50) MAOAMAOBGAANPSR1NPC1
SCHEMBL5733780 0.73 MAOA (0.50) MAOAMAOBGAANPSR1ORAI1
SCHEMBL13950592 0.73 MAOA (0.50) MAOAMAOBGAANPSR1ORAI1
SCHEMBL12773597 0.73 MAOA (0.50) MAOAMAOBGAANPSR1ORAI1
SCHEMBL7295118 0.73 MAOA (0.50) MAOAMAOBGAANPSR1ORAI1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8138177-B2 Benzimidazolone derivatives as CB2 receptor ligands PFIZER INC. (US) 2012-03-20 US disclosed
US-20090181957-A1 BENZIMIDAZOLONE DERIVATIVES AS CB2 RECEPTOR LIGANDS ANDO KAZUO 2009-07-16 US disclosed
EP-1861377-A1 BENZIMIDAZOLONE DERIVATIVES AS CB2 RECEPTOR LIGANDS Pfizer, Inc. (US) 2007-12-05 EP disclosed
WO-2006097808-A1 BENZIMIDAZOLONE DERIVATIVES AS CB2 RECEPTOR LIGANDS PFIZER JAPAN INC. (JP) 2006-09-21 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090181957-A1 BENZIMIDAZOLONE DERIVATIVES AS CB2 RECEPTOR LIGANDS TRPV1, CNR1, CNR2 MAOA 3887/4885MAOB 2708/4885GAA 3568/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.